Search Results

You are looking at 1 - 1 of 1 items for :

  • Author or Editor: Zachary Kribs x
  • Post-transplantation x
  • Refine by Content Type: All x
Clear All Modify Search
Zachary Kribs is the ASN Government Affairs Specialist

The House Energy and Commerce Committee held a hearing on Wednesday, January 8th, on the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2019, advancing a long-standing legislative priority of the American Society of Nephrology.

The legislation, introduced in late December by Representative Ron Kind and Representative Michael Burgess, along with three other original sponsors, would allow Medicare to pay for immunosuppressive drugs for kidney transplant patients for the lifetime of the organ transplant. Medicare currently reimburses immunosuppressive drug coverage for only 36 months, leaving many individuals who cannot afford other coverage at risk of losing the transplanted kidney. The legislation is a top priority of ASN and has been the focus of several advocacy initiatives, including Kidney Community Advocacy Day convened by ASN in November 2019.